Kexing Biopharm Co., Ltd.

SHSE:688136 Stock Report

Market Cap: CN¥3.3b

Kexing Biopharm Future Growth

Future criteria checks 5/6

Kexing Biopharm is forecast to grow earnings and revenue by 103.2% and 27.9% per annum respectively. EPS is expected to grow by 103.6% per annum. Return on equity is forecast to be 10.4% in 3 years.

Key information

103.2%

Earnings growth rate

103.6%

EPS growth rate

Biotechs earnings growth43.4%
Revenue growth rate27.9%
Future return on equity10.4%
Analyst coverage

Low

Last updated06 Nov 2024

Recent future growth updates

No updates

Recent updates

There's No Escaping Kexing Biopharm Co., Ltd.'s (SHSE:688136) Muted Revenues Despite A 36% Share Price Rise

Oct 08
There's No Escaping Kexing Biopharm Co., Ltd.'s (SHSE:688136) Muted Revenues Despite A 36% Share Price Rise

Kexing Biopharm Co., Ltd.'s (SHSE:688136) Share Price Boosted 36% But Its Business Prospects Need A Lift Too

May 21
Kexing Biopharm Co., Ltd.'s (SHSE:688136) Share Price Boosted 36% But Its Business Prospects Need A Lift Too

Shandong Kexing Bioproducts Co,.Ltd (SHSE:688136) Held Back By Insufficient Growth Even After Shares Climb 25%

Mar 08
Shandong Kexing Bioproducts Co,.Ltd (SHSE:688136) Held Back By Insufficient Growth Even After Shares Climb 25%

Earnings and Revenue Growth Forecasts

SHSE:688136 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,485231492193
12/31/20251,949126-972453
12/31/20241,48543-129733
9/30/20241,328-119-4441N/A
6/30/20241,370-131-145-34N/A
3/31/20241,297-169-238-47N/A
12/31/20231,259-190-278-87N/A
9/30/20231,341-87-310-55N/A
6/30/20231,335-141-413-139N/A
3/31/20231,369-128-456-122N/A
12/31/20221,316-90-485-86N/A
9/30/20221,333-37-554-81N/A
6/30/20221,31939-549-19N/A
3/31/20221,27879-38548N/A
12/31/20211,28596-27894N/A
9/30/20211,22597-198108N/A
6/30/20211,250105-80135N/A
3/31/20211,152100-71126N/A
12/31/20201,220139-83106N/A
9/30/20201,220158-2898N/A
12/31/20191,191160-485N/A
12/31/2018891942363N/A
12/31/201761659N/A65N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688136 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).

Earnings vs Market: 688136 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 688136 is expected to become profitable in the next 3 years.

Revenue vs Market: 688136's revenue (27.9% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 688136's revenue (27.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688136's Return on Equity is forecast to be low in 3 years time (10.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y